All Outputs (43)

Redox Protein Expression Predicts Radiotherapeutic Response in Early-Stage Invasive Breast Cancer Patients (2011)
Journal Article
Woolston, C. M., Al-Attar, A., Ellis, I. O., Storr, S. J., Morgan, D. A., & Martin, S. G. (2011). Redox Protein Expression Predicts Radiotherapeutic Response in Early-Stage Invasive Breast Cancer Patients. International Journal of Radiation Oncology - Biology - Physics, 79(5), 1532-1540. https://doi.org/10.1016/j.ijrobp.2010.11.002

Purpose Early-stage invasive breast cancer patients have commonly undergone breast-conserving surgery and radiotherapy. In a large majority of these patients, the treatment is effective; however, a proportion will develop local recurrence. Deregul... Read More about Redox Protein Expression Predicts Radiotherapeutic Response in Early-Stage Invasive Breast Cancer Patients.

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum (2008)
Journal Article
Storr, S. J., Royle, L., Chapman, C. J., Hamid, U. M. A., Robertson, J. F., Murray, A., …Rudd, P. M. (2008). The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology, 18(6), 456-462. https://doi.org/10.1093/glycob/cwn022

MUC1 is a high molecular weight glycoprotein that is overexpressed in breast cancer. Aberrant O-linked glycosylation of MUC1 in cancer has been implicated in disease progression. We investigated the O-linked glycosylation of MUC1 purified from the se... Read More about The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum.

Use of autoantibodies in breast cancer screening and diagnosis (2006)
Journal Article
Storr, S. J., Chakrabarti, J., Barnes, A., Murray, A., Chapman, C. J., & Robertson, J. F. (2006). Use of autoantibodies in breast cancer screening and diagnosis. Expert Review of Anticancer Therapy, 6(8), 1215-1223. https://doi.org/10.1586/14737140.6.8.1215

Breast cancer is the most common cancer among women and accounts for 6% of all cancer deaths. Current screening modalities for breast cancer diagnosis include mammography, digital mammography and magnetic resonance imaging; however, there is still an... Read More about Use of autoantibodies in breast cancer screening and diagnosis.